ArticleCancers2026
Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer.
Shengjuan Hu, Sicong Li, Yiyuan Cui, Ying Wang, Luyao Chen, Xiyuan Zhang, Li Hou, Li Feng
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Shengjuan HuDepartment of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.ORCID 0000-0002-1007-5562 Sicong LiTraditional Chinese Medicine Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.ORCID 0000-0002-6414-6645 Yiyuan CuiTraditional Chinese Medicine Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ying WangDepartment of Oncology, The Mongolia-Chinese Medical Hospital of Chifeng, Chifeng 024000, China.
Luyao ChenThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 511436, China.
Xiyuan ZhangTraditional Chinese Medicine Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li HouDepartment of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Li FengTraditional Chinese Medicine Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Funding
the National Key Research and Development Program of China 2025YFC3508300, 2025YFC3508301
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkerIL18R1machine learningsingle-cell analysissmall cell lung cancer
Identifiers
PMID42192968
PMCPMC13204795
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390